Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Deciphering DNA methylation signatures of pancreatic cancer and pancreatitis
Francesco Natale, Maria Vivo, Geppino Falco, et al.
Clinical Epigenetics (2019) Vol. 11, Iss. 1
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Trials and tribulations of pancreatic cancer immunotherapy
Daniel R. Principe, Murray Korc, Suneel D. Kamath, et al.
Cancer Letters (2021) Vol. 504, pp. 1-14
Open Access | Times Cited: 62
Integrated single-cell multiomics analysis reveals novel candidate markers for prognosis in human pancreatic ductal adenocarcinoma
Xiaoying Fan, Ping Lü, Hongwei Wang, et al.
Cell Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 42
Targeted Nanoparticle-Based Diagnostic and Treatment Options for Pancreatic Cancer
Xin Gu, Tamara Minko
Cancers (2024) Vol. 16, Iss. 8, pp. 1589-1589
Open Access | Times Cited: 12
Genetic characteristics and prognostic implications of m1A regulators in pancreatic cancer
Qingyuan Zheng, Xiao Yu, Qiyao Zhang, et al.
Bioscience Reports (2021) Vol. 41, Iss. 4
Open Access | Times Cited: 48
Cell-Free DNA Methylation: The New Frontiers of Pancreatic Cancer Biomarkers’ Discovery
Mariarita Brancaccio, Francesco Natale, Geppino Falco, et al.
Genes (2019) Vol. 11, Iss. 1, pp. 14-14
Open Access | Times Cited: 50
Polymorphic variants involved in methylation regulation: a strategy to discover risk loci for pancreatic ductal adenocarcinoma
Chiara Corradi, Giulia Lencioni, Manuel Gentiluomo, et al.
Journal of Medical Genetics (2023) Vol. 60, Iss. 10, pp. 980-986
Open Access | Times Cited: 15
The Emerging Roles of ATP-Dependent Chromatin Remodeling Complexes in Pancreatic Cancer
Nesrin M. Hasan, Nita Ahuja
Cancers (2019) Vol. 11, Iss. 12, pp. 1859-1859
Open Access | Times Cited: 37
MicroRNAs and long non-coding RNAs in pancreatic cancer: From epigenetics to potential clinical applications
Luis Alberto Bravo-Vázquez, Natalia Frías-Reid, Ana Gabriela Ramos-Delgado, et al.
Translational Oncology (2022) Vol. 27, pp. 101579-101579
Open Access | Times Cited: 22
Leveraging Epigenetic Alterations in Pancreatic Ductal Adenocarcinoma for Clinical Applications
Jörg Tost, Secil Ak-Aksoy, Daniele Campa, et al.
Seminars in Cancer Biology (2025)
Open Access
Bridging epigenomics and tumor immunometabolism: molecular mechanisms and therapeutic implications
Xiaowen Xie, Weici Liu, Zhiyuan Yuan, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
Role of Epigenetics in Pancreatic Ductal Adenocarcinoma
Somnath Pandey, Vineet K. Gupta, Shweta Lavania
Epigenomics (2023) Vol. 15, Iss. 2, pp. 89-110
Open Access | Times Cited: 10
E3 ubiquitin ligase FBXW11 as a novel inflammatory biomarker is associated with immune infiltration and NF-κB pathway activation in pancreatitis and pancreatic cancer
Peng Tan, Shuang Cai, Zhiwei Huang, et al.
Cellular Signalling (2024) Vol. 116, pp. 111033-111033
Closed Access | Times Cited: 3
Genome-wide DNA methylation and transcriptomic patterns of precancerous gastric cardia lesions
Xiaoqi Liao, Runhua Lin, Zhihua Zhang, et al.
JNCI Journal of the National Cancer Institute (2024) Vol. 116, Iss. 5, pp. 681-693
Closed Access | Times Cited: 3
Potential association between PSCA rs2976395 functional variant and pancreatic cancer risk
Chiara Corradi, Giulia Lencioni, Alessio Felici, et al.
International Journal of Cancer (2024) Vol. 155, Iss. 8, pp. 1432-1442
Closed Access | Times Cited: 3
Emerging role of non-invasive and liquid biopsy biomarkers in pancreatic cancer
Akash Bararia, Prosenjeet Chakraborty, Paromita Roy, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 15, pp. 2241-2260
Open Access | Times Cited: 8
Multi-Omic Biomarkers as Potential Tools for the Characterisation of Pancreatic Cystic Lesions and Cancer: Innovative Patient Data Integration
Laura Kane, Gregory S. Mellotte, Kevin C. Conlon, et al.
Cancers (2021) Vol. 13, Iss. 4, pp. 769-769
Open Access | Times Cited: 19
Identification of prognosis-related molecular subgroups based on DNA methylation in pancreatic cancer
Xiaoli Yin, Lingming Kong, Peng Liu
Clinical Epigenetics (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 18
Epigenetic regulation of major histocompatibility complexes in gastrointestinal malignancies and the potential for clinical interception
Jorge Enrique Tovar Perez, Shilan Zhang, William Hodgeman, et al.
Clinical Epigenetics (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 2
DNA methylome in pancreatic cancer identified novel promoter hyper-methylation in NPY and FAIM2 genes associated with poor prognosis in Indian patient cohort
A Chatterjee, Akash Bararia, Debopriyo Ganguly, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 10
Methylation of the miR‑29b‑3p promoter contributes to angiogenesis, invasion, and migration in pancreatic cancer
Lihua Wang, Nv Mu, Nina Qu
Oncology Reports (2020) Vol. 45, Iss. 1, pp. 65-72
Open Access | Times Cited: 15
High‐resolution and quantitative spatial analysis reveal intra‐ductal phenotypic and functional diversification in pancreatic cancer
Ellis Michiels, Hediel Madhloum, Silke Van Lint, et al.
The Journal of Pathology (2023) Vol. 262, Iss. 1, pp. 76-89
Open Access | Times Cited: 5
A Prognostic Prediction Model Developed Based on Four CpG Sites and Weighted Correlation Network Analysis Identified DNAJB1 as a Novel Biomarker for Pancreatic Cancer
Lingming Kong, Peng Liu, Fei Xiang, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 14
Oncogenomic Changes in Pancreatic Cancer and Their Detection in Stool
Heidelinde Sammallahti, Virinder Kaur Sarhadi, Arto Kokkola, et al.
Biomolecules (2022) Vol. 12, Iss. 5, pp. 652-652
Open Access | Times Cited: 8
Validation of SFRP1 Promoter Hypermethylation in Plasma as a Prognostic Marker for Survival and Gemcitabine Effectiveness in Patients with Stage IV Pancreatic Adenocarcinoma
Benjamin E. Stubbe, Stine Dam Henriksen, Poul Henning Madsen, et al.
Cancers (2021) Vol. 13, Iss. 22, pp. 5717-5717
Open Access | Times Cited: 11
Ehmt2 inactivation in pancreatic epithelial cells shapes the transcriptional landscape and inflammation response of the whole pancreas
Gareth Pollin, Angela Mathison, Thiago M. de Assuncao, et al.
Frontiers in Genetics (2024) Vol. 15
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top